Hachioji, Japan

Kyushichi Miyazawa

This inventor holds 1 USPTO granted patent. Top assignee: Meiji Milk Products Company, Limited. Active years: 1983.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kyushichi Miyazawa. Retrieved from https://idiyas.com/inventor/kyushichi-miyazawa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 1983

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kyushichi Miyazawa: Innovator in High Molecular Polysaccharides

Introduction

Kyushichi Miyazawa is a notable inventor based in Hachioji, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of high molecular polysaccharides. His work has implications for medical applications, especially in cancer treatment.

Latest Patents

Miyazawa holds a patent for a new high molecular polysaccharide known as MPS-80. This innovative polysaccharide was obtained by culturing bacteria from the genera Lactobacillus or Streptococcus. The MPS-80 has demonstrated an excellent anti-tumor effect, making it a promising candidate for use as an anti-tumor agent.

Career Highlights

Kyushichi Miyazawa is associated with Meiji Milk Products Company, Limited, where he continues to advance his research. His dedication to innovation in the field of polysaccharides has positioned him as a key figure in biotechnological advancements.

Collaborations

Miyazawa has worked alongside notable colleagues such as Fumiyasu Tsuchiya and Munehiro Oda. Their collaborative efforts have contributed to the success of his research and the development of new applications for polysaccharides.

Conclusion

Kyushichi Miyazawa's work in high molecular polysaccharides represents a significant advancement in biotechnology. His contributions, particularly with MPS-80, hold great promise for future medical applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…